Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 15;16(5):2241-2252.
doi: 10.4251/wjgo.v16.i5.2241.

Hepatocellular carcinoma presenting as an extrahepatic mass: A case report and review of literature

Affiliations
Case Reports

Hepatocellular carcinoma presenting as an extrahepatic mass: A case report and review of literature

Wei Kelly Wu et al. World J Gastrointest Oncol. .

Abstract

Background: Hepatocellular carcinoma (HCC) is a primary liver tumor generally diagnosed based on radiographic findings. Metastatic disease is typically associated with increased tumor diameter, multifocality, and vascular invasion. We report a case of a patient who presented with extrahepatic HCC metastasis to a portocaval lymph node with occult hepatic primary on computed tomography (CT). We review the literature for cases of extrahepatic HCC presentation without known hepatic lesions and discuss strategies to differentiate between metastatic and ectopic HCC.

Case summary: A 67-year-old male with remotely treated hepatis C was referred for evaluation of an enlarging portocaval, mixed cystic-solid mass. Serial CT evaluations demonstrated steatosis, but no cirrhosis or liver lesions. Endoscopic ultrasound demonstrated a normal-appearing pancreas, biliary tree, and liver. Fine needle aspiration yielded atypical cells. The differential diagnosis included duodenal or pancreatic cyst, lymphoproliferative cyst, stromal or mesenchymal lesions, nodal involvement from gastrointestinal or hematologic malignancy, or duodenal gastro-intestinal stromal tumor. After review by a multidisciplinary tumor board, the patient underwent open surgical resection of a 5.2 cm × 5.5 cm retroperitoneal mass with pathology consistent with moderately-differentiated HCC. Magnetic resonance imaging (MRI) subsequently demonstrated a 1.2 cm segment VIII hepatic lesion with late arterial enhancement, fatty sparing, and intrinsic T1 hyperintensity. Alpha fetoprotein was 23.3 ng/mL. The patient was diagnosed with HCC with portocaval nodal involvement. Review: We surveyed the literature for HCC presenting as extrahepatic masses without history of concurrent or prior intrahepatic HCC. We identified 18 cases of extrahepatic HCC ultimately found to represent metastatic lesions, and 30 cases of extrahepatic HCC found to be primary, ectopic HCC.

Conclusion: Hepatocellular carcinoma can seldomly present with extrahepatic metastasis in the setting of occult primary. In patients with risk factors for HCC and lesions suspicious for metastatic disease, MRI may be integral to identifying small hepatic lesions and differentiating from ectopic HCC. Tumor markers may also have utility in establishing the diagnosis.

Keywords: Case report; Extrahepatic; Lymph node; Metastasis; Portocaval.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Lesion growth on computed tomography. Serial intravenous-contrasted Computed tomography scans of the abdomen and pelvis demonstrated increase in size of the patient’s portocaval mass (arrows). A: 3.6 cm × 2 cm, 8 months prior to presentation; B: 5.2 cm × 3.2 cm, time of presentation.
Figure 2
Figure 2
Histopathologic evaluation of the resected mass. A: Hematoxylin and eosin staining at low and high magnification reveals vague nodules of large polygonal cells with eosinophilic granular to clear vacuolated cytoplasm, steatotic and clear-cell changes, increased mitosis, necrosis and rare hyaline bodies; B: Immunohistochemistry demonstrates positive staining for HepPar1, arginase-1, and glypican-3.
Figure 3
Figure 3
Magnetic resonance imaging of the liver. Magnetic resonance imaging abdomen demonstrated a 1.2 cm lesion in segment VIII with late arterial enhancement, fatty sparing, and intrinsic T1 hyperintensity. A: T1-weighted, pre-contrast; B: T1-weighted immediate post-contrast; C: T1-weighted, 5 min post-contrast.

References

    1. Kanwal F, Singal AG. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction. Gastroenterology. 2019;157:54–64. - PMC - PubMed
    1. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–750. - PubMed
    1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. - PubMed
    1. Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, Hiramatsu A, Kodama H, Takahashi S, Chayama K. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007;13:414–420. - PMC - PubMed
    1. Yi J, Gwak GY, Sinn DH, Kim YJ, Kim HN, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1. Hepatogastroenterology. 2013;60:328–332. - PubMed

Publication types